Zopiclone
is a sedative-hypnotic medication used to treat insomnia. The market for zopiclone is driven by the increasing prevalence of insomnia and sleep disorders worldwide. Growing awareness about the side effects of zopiclone, including addiction and dependence, is expected to hamper market growth. The availability of alternative therapies such as cognitive behavioral therapy for insomnia (CBTI) and non-pharmacological interventions is also a factor that may limit the growth of the zopiclone market. However, the development of new formulations with reduced side effects and improved efficacy, as well as increasing investment in research and development, are expected to create new opportunities in the market. The market is also influenced by government policies, regulations, and reimbursement policies for zopiclone and other sleep medications.
Key Companies in the Zopiclone Industry:
Dr. Reddy’s Laboratories Ltd.
Founded in 1984, Dr. Reddy’s Laboratories is an Indian multinational pharmaceutical company with its headquarters in Hyderabad, Telangana. The company operates in over 20 countries and is among the top generics manufacturers worldwide. In August 2021, the company received approval from the USFDA for its Zopiclone tablets, which are used to treat insomnia.
Glenmark Pharmaceuticals Limited
Founded in 1977, Glenmark Pharmaceuticals is an Indian multinational pharmaceutical company with its headquarters in Mumbai, Maharashtra. The company operates in over 80 countries and is among the leading players in the pharmaceutical industry. In 2020, Glenmark received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its Zopiclone tablets.
Hikma Pharmaceuticals PLC
Founded in 1978, Hikma Pharmaceuticals is a multinational pharmaceutical company with its headquarters in London, UK. The company operates in over 50 countries and is a major player in the pharmaceutical industry. In 2020, Hikma received approval from the USFDA for its Zopiclone tablets.
Lupin Pharmaceuticals Inc.
Founded in 1968, Lupin Pharmaceuticals is an Indian multinational pharmaceutical company with its headquarters in Mumbai, Maharashtra. The company operates in over 100 countries and is among the leading players in the pharmaceutical industry. In 2020, Lupin received approval from the USFDA for its Zopiclone tablets.